Filing Details

Accession Number:
0001209191-21-004767
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-21 20:17:20
Reporting Period:
2021-01-19
Accepted Time:
2021-01-21 20:17:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1718108 Surface Oncology Inc. SURF () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1656435 Jeff Goater C/O Surface Oncology, Inc.
50 Hampshire Street, 8Th Floor
Cambridge MA 02139
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-19 5,000 $3.18 267,000 No 4 M Direct
Common Stock Disposition 2021-01-19 5,000 $13.00 262,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-19 5,000 $0.00 5,000 $3.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
252,000 2030-02-03 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020.
  2. This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates.